Randomized trial of standard chemotherapy alone or combined with atezolizumab as adjuvant therapy for patients with stage III deficient DNA mismatch repair (dMMR) colon cancer (Alliance A021502; ATOMIC).

Frank A. Sinicrope, Jeffrey A. Meyerhardt, Walter R. Peters et al.|Journal of Clinical Oncology|2025

Cited by 47